Comparison of the Hemodynamic Changes in Usage of Intratracheal Intubation and Laryngeal Mask in Patients under Anesthesia

Comparison of the Hemodynamic Changes in Usage of Direct Intratracheal Intubation and Laryngeal Mask in Patients under General Anesthesia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014110619037N3

Enrollment

200

Registered

2014-11-17

Start date

2013-10-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Heart rate instability due to intubation. Condition 2: Blood pressure instability due to intubation. - -

Interventions

Intervention 1: First intervention group: Using of intubation tube for direct intubation from SUPA company, Iran, registered No. 24422. Intervention 2: Second intervention group: Using of laryngeal ma

First intervention group: Using of intubation tube for direct intubation from SUPA company, Iran, registered No. 24422

Second intervention group: Using of laryngeal maskfor intubation from Cerdas Seimbang Sdn. Bhd. company, Malaysia, registered No. 130601

Eligibility

Sex/Gender

All

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients between 20 to 50 years of age who are candidate for surgery under general anesthesia and are in ASA class 1 (The American Society of Anesthesiologists Physical Status classification system): Normal healthy patients with no organic, physiologic, or psychiatric disturbance. Exclusion criteria: Patients who use anti-hypertensive, analgesic or sedative agents; patients who need urgent intubation; patients who are not NPO (nil per os); difficult intubation; diabetic patients.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Mean heart rate. Timepoint: 1 minute before intubation and 1, 2, 3, 4, 5 and 10 minutes after intubation. Method of measurement: The monitor device.;Mean systolic blood pressure. Timepoint: 1 minute before intubation and 1, 2, 3, 4, 5 and 10 minutes after intubation. Method of measurement: The monitor device.;Mean diastolic blood pressure. Timepoint: 1 minute before intubation and 1, 2, 3, 4, 5 and 10 minutes after intubation. Method of measurement: The monitor device.;Mean arterial blood pressure. Timepoint: 1 minute before intubation and 1, 2, 3, 4, 5 and 10 minutes after intubation. Method of measurement: The monitor device.	—

Measure

Time frame

Mean heart rate. Timepoint: 1 minute before intubation and 1, 2, 3, 4, 5 and 10 minutes after intubation. Method of measurement: The monitor device.;Mean systolic blood pressure. Timepoint: 1 minute before intubation and 1, 2, 3, 4, 5 and 10 minutes after intubation. Method of measurement: The monitor device.;Mean diastolic blood pressure. Timepoint: 1 minute before intubation and 1, 2, 3, 4, 5 and 10 minutes after intubation. Method of measurement: The monitor device.;Mean arterial blood pressure. Timepoint: 1 minute before intubation and 1, 2, 3, 4, 5 and 10 minutes after intubation. Method of measurement: The monitor device.

—

Secondary

Measure	Time frame
-. Timepoint: -. Method of measurement: -.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026